THYROID ASSOCIATED OPHTHALMOPATHY
Clinical trials for THYROID ASSOCIATED OPHTHALMOPATHY explained in plain language.
Never miss a new study
Get alerted when new THYROID ASSOCIATED OPHTHALMOPATHY trials appear
Sign up with your email to follow new studies for THYROID ASSOCIATED OPHTHALMOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
3D-Printed guides could make thyroid eye surgery safer
Disease control CompletedThis study tested whether using 3D-printed, custom models to plan and guide orbital decompression surgery leads to fewer complications and better outcomes for people with thyroid eye disease. Twelve adults with inactive, moderate-to-severe disease were randomly assigned to receiv…
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHY
Phase: NA • Sponsor: Althaia Xarxa Assistencial Universitària de Manresa • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New antibody shows promise for tough thyroid eye disease
Disease control CompletedThis study tested a drug called IBI311 in 53 people with thyroid eye disease that did not get better with steroids. The drug is a modified antibody that blocks a specific receptor. The main goal was to see if it could reduce eye bulging. The trial was completed and compared IBI31…
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHY
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis study tested a new medicine called LASN01 in 41 adults with thyroid eye disease, a condition that causes eye bulging and discomfort. The goal was to see if LASN01 could safely reduce eye bulging compared to a placebo. Participants received either LASN01 or a dummy treatment …
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHY
Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC